BioCentury
ARTICLE | Company News

Mallinckrodt, Ikaria deal

March 9, 2015 7:00 AM UTC

Mallinckrodt will acquire Ikaria for $2.3 billion from an investor group led by private equity firm Madison Dearborn Partners. Ikaria markets INOmax inhaled nitric oxide to treat hypoxic respiratory...